An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma.
Abstract
OBJECTIVES
We measured the serum concentration of a panel of inflammatory cytokines and evaluated their association with circulating
proangiogenic biomarkers and with outcome in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS
We collected serum samples from 36 patients with PDAC, 9 patients with chronic pancreatitis, and 22 healthy volunteers as
a control. Inflammatory cytokines and proangiogenic biomarkers were measured using the multianalyte xMAP array and carcinoembryonic
antigen (CEA) and carbohydrate 19-9 by immunoassay.
RESULTS
Patients with PDAC had higher circulating levels of interleukin 6 (IL-6) than those of patients with pancreatitis or healthy
individuals and higher levels of IL-10 and tumor necrosis factor α (TNF-α) compared with those of healthy individuals. In
patients with PDAC, circulating IL-6, TNF-α, IL-1β, and IL-10 correlated with serum concentrations of vascular endothelial
growth factor and basic fibroblast growth factor; circulating IL-6, IL-1β, and TNF-α correlated with carbohydrate 19-9; and
IL-8, IL-10, and TNF-α correlated with CEA levels. Circulating IL-8, TNF-α, and CEA; tumor stage; and lymph node metastases
were associated with a poor outcome.
CONCLUSIONS
The results of this exploratory study indicate that inflammatory cytokines should be pursued as potential prognostic biomarkers
as well as targets for therapy in larger studies in PDAC.
Links
Authors
Dima SO, Tanase C, Albulescu R, Herlea V, Chivu-Economescu M, Purnichescu-Purtan R, Dumitrascu T, Duda DG, Popescu I
Institution
Center of Digestive Disease and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
Source
Pancreas 41:7 2012 Oct pg 1001-7MeSH
AdultAged
CA-19-9 Antigen
Carcinoembryonic Antigen
Carcinoma, Pancreatic Ductal
Cytokines
Female
Fibroblast Growth Factor 2
Humans
Interleukin-10
Interleukin-1beta
Interleukin-6
Macrophages
Male
Middle Aged
Pancreatic Neoplasms
Prognosis
Tumor Markers, Biological
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22722257
Log In

